Bio Usawa, Inc. proudly announces that its CEO, Co-Founder and President Dr. Menghis Bairu is a recipient of a prestigious 2025 African Diaspora Luminaire Award.
The African Diaspora Luminaire Awards recognize distinguished African Diasporans making high-level impact on a global scale. African Diaspora Network (ADN) annually celebrates luminaires who have made exceptional contributions and demonstrate a commitment to advance the African continent and the communities in which we live. Recipients of the award are individuals who have made a significant difference through leadership in their field, their commitment to ADN, and/or through their leadership and advancements.
This recognition reflects the importance of Bio Usawa’s collective mission and the advancements made by its leadership towards the company’s commitment to make transformative biomedicines in Africa, by Africans, for Africans and beyond.
This years’ awards will be presented at the 10th annual African Diaspora Investment Symposium on May 29th during the ADIS25 Conference.
Bio Usawa has a singular mission: to manufacture and commercialize high-quality, effective and affordable biosimilars for patients in Africa. We are applying our 100+ years of combined experience in the industry in partnership with governments, agencies, educators and health professionals to make transformative biomedicines in Africa, by Africans, for Africans and beyond.
Click here to learn more about our company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.
For generations, many of the world’s most advanced biologic medicines have been developed and manufactured far from Africa. But what if Africa could bu…
October 2026Bio Usawa is proud to celebrate Dr. Aida Habtezion, a member of our Board of Directors, on her new role as a Global Health Faculty Fellow at the Stanfor…
October 2026Bio Usawa Biotechnology today announced the launch of Bio Usawa Biotech Botswana (Pty) Ltd, marking an important milestone in the company’s mission to b…
October 2026